Opioid-dopamine interactions: implications for substance use disorders and their treatment.
Volkow
Nora D
ND
National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Blvd., Mail Stop Code: 9581 Suite 5274, Bethesda, MD 20892, USA. nvolkow@nida.nih.gov
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D013287:Illicit Drugs / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000378:metabolism*; D011957:Receptors, Opioid / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000378:metabolism
D013287:Illicit Drugs; D011954:Receptors, Dopamine; D011957:Receptors, Opioid